BC-DXI-843 is a potent and specific AIMP2-DX2 inhibitor with an IC50 of 0.92 µM, more than 100-fold selectivity over AIMP2 (IC50 >100 µM) in a luciferase assay. BC-DXI-843 acts as a promising lead targeting AIMP2-DX2 in lung cancer[1].
Molecular Weight:
546.66
Purity:
99.76
CAS Number:
[2421117-98-6]
Formula:
C28H26N4O4S2
Target:
Aminoacyl-tRNA Synthetase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
